Your browser doesn't support javascript.
loading
miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcome.
Papadimitriou, Maria-Alexandra; Papanota, Aristea-Maria; Adamopoulos, Panagiotis G; Pilala, Katerina-Marina; Liacos, Christine-Ivy; Malandrakis, Panagiotis; Mavrianou-Koutsoukou, Nefeli; Patseas, Dimitrios; Eleutherakis-Papaiakovou, Evangelos; Gavriatopoulou, Maria; Kastritis, Efstathios; Avgeris, Margaritis; Dimopoulos, Meletios-Athanasios; Terpos, Evangelos; Scorilas, Andreas.
Afiliación
  • Papadimitriou MA; Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.
  • Papanota AM; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, "Alexandra" General Hospital, Athens, Greece.
  • Adamopoulos PG; Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.
  • Pilala KM; Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.
  • Liacos CI; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, "Alexandra" General Hospital, Athens, Greece.
  • Malandrakis P; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, "Alexandra" General Hospital, Athens, Greece.
  • Mavrianou-Koutsoukou N; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, "Alexandra" General Hospital, Athens, Greece.
  • Patseas D; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, "Alexandra" General Hospital, Athens, Greece.
  • Eleutherakis-Papaiakovou E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, "Alexandra" General Hospital, Athens, Greece.
  • Gavriatopoulou M; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, "Alexandra" General Hospital, Athens, Greece.
  • Kastritis E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, "Alexandra" General Hospital, Athens, Greece.
  • Avgeris M; Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.
  • Dimopoulos MA; Laboratory of Clinical Biochemistry-Molecular Diagnostics, Second Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, "P. & A. Kyriakou" Children's Hospital, Athens, Greece.
  • Terpos E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, "Alexandra" General Hospital, Athens, Greece.
  • Scorilas A; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, "Alexandra" General Hospital, Athens, Greece. eterpos@med.uoa.gr.
Br J Cancer ; 126(1): 79-90, 2022 01.
Article en En | MEDLINE | ID: mdl-34718359

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Plasmáticas / Regulación Neoplásica de la Expresión Génica / Análisis de Secuencia de ARN / MicroARNs / Sindecano-1 / Mieloma Múltiple Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Br J Cancer Año: 2022 Tipo del documento: Article País de afiliación: Grecia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Plasmáticas / Regulación Neoplásica de la Expresión Génica / Análisis de Secuencia de ARN / MicroARNs / Sindecano-1 / Mieloma Múltiple Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Br J Cancer Año: 2022 Tipo del documento: Article País de afiliación: Grecia